Afferent Pharmaceuticals
San Mateo, US · Delaware corporation · 1 employees on LinkedIn · 5 known investors
Founders & leadership
AF
Anthony FordinFounder, Chief Scientist2009–2016
MK
Michael KittinChief Medical Officer2013–2017
KS
Kathleen Sereda GlaubinCEO2014–2016
Board
KS
AP
Arthur PappasBoard director
LR
Liam RatcliffeBoard director
JT
PH
Peter HirthBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$55M disclosed across 1 round · 2015
▶$55MraisedJul 2015 · 17 investors · PharmaceuticalsRule 506(b)
▶$55MraisedJul 2015 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin StarrDirector
- Michael KittExecutive Officer
- Arthur PappasDirector
- Anthony FordExecutive Officer
- Kathleen Sereda GlaubExecutive Officer, Director
- Peter HirthDirector
- Liam RatcliffeDirector
- Jesse TreuDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Afferent Pharmaceuticals?
- Afferent Pharmaceuticals was founded by Anthony Ford.
- Who are Afferent Pharmaceuticals's investors?
- Afferent Pharmaceuticals's investors include Pappas Capital, Domain Associates, Fidelity Investments, Jennison Associates, Third Rock Ventures.
- How much funding has Afferent Pharmaceuticals raised?
- Afferent Pharmaceuticals has disclosed $55M raised across 1 round.
- Where is Afferent Pharmaceuticals headquartered?
- Afferent Pharmaceuticals is headquartered in San Mateo, US.